Evidence map›Paper›PMID 27073928›Full record

ArticlePloS one2016

Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.

M Katherine Charles, Mary Lou Lindegren, C William Wester, Meridith Blevins, Timothy R Sterling, Nguyen Thi Dung, Jean Claude Dusingize, Divine Avit-Edi, Nicolas Durier, Barbara Castelnuovo and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 6 countries.

M Katherine CharlesVanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
Mary Lou LindegrenVanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
C William WesterVanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
Meridith BlevinsVanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
Timothy R SterlingVanderbilt Univ. School of Medicine, Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, United States of America.
Nguyen Thi DungNational Hospital of Tropical Diseases, Hanoi, Vietnam.
Jean Claude DusingizeWomen's Equity in Access to Care & Treatment, Kigali, Rwanda.
Divine Avit-EdiMTCTPlus, Abidjan, Cote d'Ivoire.
Nicolas DurierTREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand.
Barbara CastelnuovoInfectious Disease Institute, Kampala, Uganda.
Gertrude NakigoziRakai Health Sciences Program, Kalisizo, Uganda.
Claudia P CortesUniversity of Chile School of Medicine, Santiago, Chile.
Marie BallifInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Lukas FennerInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration
Vanderbilt University · USInstitute of Social and Preventive Medicine · CHHospital for Tropical Diseases · VNInfectious Diseases Institute · UGRakai Health Sciences Program · UGUniversity of Chile · CLUniversity of Global Health Equity · RWVanderbilt Health · US

Funding

East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional ConsortiumU01AI069911 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI AGGREY SEMWENDERO SEMEERE, Kara Kay Wools-Kaloustian · 2006 to 2026
$57.7M
Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
The Asia-Pacific HIV Research CollaborationU01AI069907 · NIAID · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN · 2006 to 2026
$44.8M
CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
WADA (West Africa Database on Antiretroviral Therapy) CollaborationU01AI069919 · NIAID · UNIVERSITY OF BORDEAUX II · PI Didier Koumavi Ekouevi, Antoine Jaquet · 2006 to 2026
$29.9M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
GHESKIO HIV Clinical Trial UnitUM1AI069421 · NIAID · GHESKIO CENTER · PI JEAN WILLIAM PAPE · 2012 to 2026
$23.6M
leDEA Networks Coordinating Center at VanderbiltU01AI096186 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LINDEGREN, MARY LOU, WESTER, C. WILLIAM · 2011 to 2015
$2.3M
NIAID NIH HHS U01 AI069907NIAID NIH HHS U01AI069907NIAID NIH HHS U01 AI069911NIAID NIH HHS U01AI069911NIAID NIH HHS U01 AI069919NIAID NIH HHS U01AI069919NIAID NIH HHS U01 AI069923NIAID NIH HHS U01AI069923NIAID NIH HHS U01 AI069924NIAID NIH HHS U01AI069924NIAID NIH HHS U01 AI096186NIAID NIH HHS U01AI096186NIAID NIH HHS UM1 AI069421NIAID NIH HHS UM1 AI069476PHS HHS U01A096299
6 · The paper itself

Abstract

settingWorld Health Organization advocates for integration of HIV-tuberculosis (TB) services and recommends intensive case finding (ICF), isoniazid preventive therapy (IPT), and infection control ("Three I's") for TB prevention and control among persons living with HIV.

objectiveTo assess the implementation of the "Three I's" of TB-control at HIV treatment sites in lower income countries.

designSurvey conducted between March-July, 2012 at 47 sites in 26 countries: 6 (13%) Asia Pacific, 7 (15%), Caribbean, Central and South America, 5 (10%) Central Africa, 8 (17%) East Africa, 14 (30%) Southern Africa, and 7 (15%) West Africa.

resultsICF using symptom-based screening was performed at 38% of sites; 45% of sites used symptom-screening plus additional diagnostics. IPT at enrollment or ART initiation was implemented in only 17% of sites, with 9% of sites providing IPT to tuberculin-skin-test positive patients. Infection control measures varied: 62% of sites separated smear-positive patients, and healthcare workers used masks at 57% of sites. Only 12 (26%) sites integrated HIV-TB services. Integration was not associated with implementation of TB prevention measures except for IPT provision at enrollment (42% integrated vs. 9% non-integrated; p = 0.03).

conclusionsImplementation of TB screening, IPT provision, and infection control measures was low and variable across regional HIV treatment sites, regardless of integration status.

Indexed as

Infection ControlAfricaAIDS-Related Opportunistic InfectionsAntitubercular AgentsAsiaCaribbean RegionHIV InfectionsHumansIsoniazidPovertySouth AmericaTuberculosisWorld Health OrganizationAntitubercular AgentsIsoniazid

Identifiers

PMID27073928
PMCPMC4830552
OpenAlexW2340153265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.